Maximum drop of 96.24%! 113 injection belt volume procurement selected

Pharmaceutical Network February 19th, Wuhan Pharmaceuticals Joint Procurement Office announced the first batch of drugs in Hubei Province centralized band procurement results, 29 injection varieties all successfully purchased, a total of 113 drugs selected.
according to the Changjiang Daily, compared with the lowest online price in the country, the highest drop in the selection price was 85.38 percent, compared with the highest price in Hubei Province, the highest drop in the selection price reached 96.24 percent.
understand that 28 of the 29 injection varieties are antibiotics, can be described as a large-scale special procurement around antibiotic injections.
comb found that North China Pharmaceuticals, Ruiyang Pharmaceuticals, China Pharmaceutical Group Wichida Pharmaceuticals, Shandong Lu Anti, Shi Pharmaceutical Group, Zhongno Pharmaceuticals, Shandong Qidu, Hainan General Sanyo and other enterprises selected more drugs.
is also worth noting that, in accordance with the regulations, this batch of non-selected drugs will stop using in Wuhan area.
The unelected drug Wuhan deactivated from the variety point of view, Hubei's first batch of 29 varieties included in the volume procurement of all injections, in addition to the treatment of bronchial asthma dosso-tea base, the remaining varieties are all antibiotics, mainly penicillin, quinoxone antibiotics, including fluoxyxacin, cycloproxacin, amoxicillin, taclin, etc., are clinically commonly used injection varieties.
, Wuhan Pharmaceuticals Joint Procurement Office announced the results of the first batch of centralized drug belt procurement in Hubei Province.
, the Changjiang Daily reported that a number of commonly used injection varieties fell significantly.
, compared with the lowest online price in the country, the average decrease in the proposed bid price was 31.51 percent.
the average decrease of the proposed selection price compared with the list price in Hubei Province was 37.94 percent.
the industry, the decline in medicines is significantly related to the amount of pre-procurement of these drugs.
Among them, the highest amount of pre-procurement of left oxyfluorosa star, 18 specifications of procurement volume of more than 12 million (branch, bag, bottle), a number of enterprises to participate in the competition, competition is extremely fierce, and finally, Yangzijiang Pharmaceuticals, Colum, Qidu, Wu Traditional Chinese medicine and other 16 pharmaceutical companies selected.
In addition, the total reported volume of the three specifications of Amoxirin/Kravi acid is more than 10 million units, 1.2g (5:1) specifications are more than 7 million units, and finally by Suzhou Yiye, North China Pharmaceuticals, Kazakhstan Pharmaceutical Group Pharmaceutical Factory, Zhuhai Federal 4 pharmaceutical companies selected.
addition, the reported quantities of pyrasilentazine, pyracirin Shubatan and ampicillin are also considerable.
as the only non-antibiotic, Dosso-tea base is also the country's fourth batch of drug collection varieties, the variety in the public hospital market in 2019 sales have exceeded 3 billion yuan.
hubei belt procurement results show that dosso-tea base by Shandong Qidu Pharmaceuticals, Wuhan Pusheng Pharmaceuticals, Shaanxi Bosen Biopharmaceuticals, Kaifeng Connolly Pharmaceuticals 4 pharmaceutical companies selected.
it is worth noting that, in accordance with the provisions of the "Details of the implementation of the first batch of centralized drug belt procurement in Hubei Province", all non-selected varieties of the same generic name will be included in the monitoring and management, and the purchase amount shall not exceed the selected varieties of the same generic name.
the same time, this batch of non-selected drugs will stop being used in Wuhan area, and if the non-selected drugs are used due to clinical needs, they shall be implemented in accordance with the provisions of Wuhan City's record-keeping procurement.
special procurement or has been rolled out since the provincial level to carry out strip procurement, antibiotics have become a key target, many regions will be antibiotics into the belt procurement list.
city of Jinhua specialized in the original research antimicrobial mining, involving a total of 24 drugs.
intranet data show that in 2018, China's public medical institutions end-use anti-bacterial drug sales rose to 158.9 billion yuan, but in recent years, affected by the policy, the growth rate showed a downward trend.
industry believes that antimicrobial drugs are basically one of the largest use of one of the categories, and antimicrobials are highly alternative, manufacturers, supply is relatively adequate, with the conditions for volume procurement.
, the purchase of antibacterial drug belt volume is imperative.
in addition to special procurement around antibiotics, special procurement of various types of drugs is also pouring out.
the first batch of jiangxi with volume procurement selection to digestive system treatment drugs mainly.
Jiangxi Province Health Insurance Bureau, the relevant person in charge has said that Jiangxi's future drug centralized belt procurement, will be in accordance with this line of thinking, focusing on a single system, fields and diseases, in batches gradually advanced.
sources pointed out that this year the number of provincial-level procurement volume or not less than 50.
, Chongqing said it would explore the procurement of the top 500 drug varieties outside the national organization, and explore the centralized procurement of non-over-evaluated chemical and biological drugs.
also came out of Guangdong, will start 500 varieties with volume procurement work.
In accordance with the latest "Opinions on Promoting the Normalization and Institutionalization of the Procurement of Drug Concentration and Volume" issued by the State Office, the State will organize the centralized belt procurement of some drugs that have passed the consistent evaluation, carry out special procurement according to market conditions, and guide the procurement work in various places.
future, all kinds of special procurement or one after another spread.